Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 6Recruiting 6Completed 4Withdrawn 2Active not recruiting 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1Classical hematology 1

Conditions

Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1

Interventions

Oxaliplatin 87Bevacizumab 68Capecitabine 65Fluorouracil 48tislelizumab 41Gemcitabine 41Drug Therapy 41Leucovorin 38sintilimab 36Irinotecan 35lenvatinib 28Cisplatin 27HMPL-013 24S 1 (combination) 23camrelizumab 22Immune Checkpoint Inhibitors 21irinotecan sucrosofate 20apatinib 20Surgical Procedures, Operative 20Radiotherapy 20Injections 20Paclitaxel 19130-nm albumin-bound paclitaxel 19toripalimab 18Folfox protocol 17pembrolizumab 15Immunotherapy 15Cetuximab 15Specimen Handling 14Radiosurgery 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Metronidazole × Gastrointestinal × Clear all
NCT05720559 2023-02-09

Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC Detection

Liaoning Cancer Hospital & Institute

Phase 2 Not yet recruiting
100 enrolled
Gastrointestinal

Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡